|
Peter Felding (Copenhagen):
"Criteria for including and excluding reference individuals"
(in NORIP)
Recruitment
Reference individuals could be recruited from
- the laboratory personnel
- and their relatives
- or acquaintances,
- from new blood donors or ones that seldom donate blood.
In fact potentially from any one fulfilling the criteria.
Equal sex and age distributions were sought according to the protocol.
Note:
- The individuals were not recruited randomly from age and sex groups in a given
population as in the Skåne study (1999)1 or in the Vejle glucose study
(2001)2
- Potential reference individuals excluded themselves before entering the study if they
did not fulfill the inclusion criteria.
1: Back SE, Nilsson JE, Fex G, Jeppson JO, Rosen U, Tryding N, von Schenck H, Norlund
L. Towards common reference intervals in clinical chemistry. An attempt at harmonization
between three hospital laboratories in Skane, Sweden. Clin Chem Lab Med 1999
May;37(5):573-92.
2: Jorgensen LG, Stahl M, Brandslund I, Hyltoft Petersen P, Borch-Johnsen K, de Fine
Olivarius N.
Plasma glucose reference interval in a low-risk population. 2. Impact of the new WHO
and ADA recommendations on the diagnosis of diabetes mellitus.Scand J Clin Lab Invest 2001
May;61(3):181-90.
Criteria for inclusion
The reference individual should
- be feeling subjectively well
- have reached the age of 18
- not be pregnant or breast-feeding
- not have been an in-patient in a hospital nor been subjectively dangerously ill during
the last month
- not have had more than 2 measures of alcohol (24 g) in the last 24 hours
- not have given blood as a donor in the last five months
- not have taken prescribed drugs other than the P-pill or estrogens (female sex hormone)
during the last two weeks
- not have smoked in the last hour prior to blood sampling
Exclusions of values from reference individuals can originate from exclusion of:
- Whole individuals based on their personal properties or habits
.
(main issue of present talk)
- Analytical series from laboratories
- Single results
- as outliers (will be done in NORIP if appropiate)
- because of certain disease ( Is not done in NORIP (yet) . Is used in the Skåne study)
- because of certain medikation (Is not done in NORIP (yet) . Is used in the Skåne study)
- because of certain condition: e.g. CK values from persons with extreme physical activity
within the last week. This has been done in Norip.
Original criteria for exclusion of individuals:
Plasma- or serum-Glucose over 11.0 mmol/L
Other analytical results that clearly point to a disease
At present (10.08.2002) the exclusions rules for individuals are:
Glucose concentration > 7.00 mmol/l in thawed serum from individuals, who had fasted
more than 8 h. If results from fresh or thawed plasma are available, these too should be
> 7.00 mmol/l.
Glucose concentration > 11.00 mmol/l in thawed serum. If results from fresh or thawed
plasma are available, these too should be > 11.00 mmol/l.
5s3s *: Results on thawed serum exceeding median (Norip) + 5s (Malmø/Odense) for one
component and median (Norip)+ 3 s (Malmø/Odense) for another component. If other
materials have been analyzed the rule should be fulfilled for the two considered
components in at least one of the additional materials.
4s4s*: Results on thawed serum exceeding median (Norip) + 4s (Malmø/Odense) for one
component and median (Norip)+ 4 s (Malmø/Odense) for another component. If other
materials have been analyzed the rule should be fulfilled for the two considered
components in at least one of the additional materials.
* The 5s3s and 4s4s rules was not be applied on low values of ALT, AST, CK, GT, ALP, LD
, Creatinine, Carbamid(Urea), Triglycerides and/or Bilirubin
Limits used:
Limits used have yellow
background (limits with grey background have no clinical interest)
|
|
Limits for both gender or men if separate limits for women |
Women |
| Component |
CAL target |
-5s |
-3s |
median |
+3s |
+5s |
-5s |
-3s |
median |
+3s |
+5s |
Na |
137.60 |
131.81 |
135.55 |
141.37 |
147.43 |
151.62 |
|
|
|
|
|
Ca |
2.27 |
1.94 |
2.09 |
2.34 |
2.62 |
2.83 |
|
|
|
|
|
Mg |
0.81 |
0.58 |
0.67 |
0.84 |
1.05 |
1.21 |
|
|
|
|
|
P inorg |
1.03 |
0.50 |
0.69 |
1.13 |
1.85 |
2.58 |
|
|
|
|
|
Uric acid |
285.00 |
131.83 |
190.09 |
329.14 |
569.92 |
821.79 |
79.32 |
123.90 |
241.89 |
472.24 |
737.66 |
Cholesterol |
4.94 |
1.83 |
2.78 |
5.20 |
9.73 |
14.78 |
|
|
|
|
|
Trigly |
1.31 |
0.10 |
0.26 |
1.00 |
3.88 |
9.58 |
|
|
|
|
|
Bilirubin |
8.50 |
1.39 |
3.04 |
9.80 |
31.57 |
68.86 |
|
|
|
|
|
ALP |
141.50 |
32.80 |
58.11 |
137.04 |
323.21 |
572.66 |
|
|
|
|
|
Amylase |
192.80 |
35.61 |
70.15 |
193.96 |
536.28 |
1056.43 |
|
|
|
|
|
AST |
23.70 |
6.73 |
11.32 |
24.69 |
53.86 |
90.60 |
5.69 |
9.56 |
20.79 |
45.22 |
75.90 |
K |
3.70 |
2.99 |
3.38 |
4.06 |
4.88 |
5.51 |
|
|
|
|
|
Alt |
17.80 |
2.14 |
5.47 |
22.40 |
91.76 |
234.91 |
1.98 |
4.65 |
16.70 |
59.93 |
140.50 |
CK |
118.80 |
6.96 |
21.81 |
120.96 |
670.78 |
2101.57 |
6.36 |
17.59 |
81.00 |
372.95 |
1032.19 |
LD |
264.00 |
134.01 |
187.16 |
308.88 |
509.76 |
711.91 |
|
|
|
|
|
Fe |
20.23 |
3.31 |
6.53 |
18.10 |
50.21 |
99.10 |
|
|
|
|
|
TIBC |
63.20 |
29.06 |
39.07 |
60.90 |
94.95 |
127.65 |
|
|
|
|
|
GT |
35.90 |
1.98 |
5.52 |
25.81 |
120.63 |
337.22 |
1.58 |
4.20 |
18.21 |
78.94 |
209.92 |
HDL |
1.33 |
0.44 |
0.69 |
1.33 |
2.58 |
4.01 |
0.55 |
0.85 |
1.64 |
3.17 |
4.93 |
Creatinin |
69.60 |
43.41 |
54.75 |
77.54 |
109.81 |
138.49 |
35.65 |
45.23 |
64.64 |
92.37 |
117.19 |
Urea |
4.94 |
1.78 |
2.79 |
5.50 |
10.83 |
17.02 |
1.32 |
2.17 |
4.60 |
9.74 |
16.06 |
Protein |
67.10 |
52.41 |
58.74 |
69.70 |
82.70 |
92.68 |
|
|
|
|
|
Albumin |
40.80 |
30.77 |
35.05 |
42.59 |
51.76 |
58.95 |
29.54 |
33.71 |
41.09 |
50.08 |
57.15 |
Glucose |
4.49 |
2.67 |
3.41 |
4.90 |
7.04 |
8.97 |
|
|
|
|
|
28 individuals were excluded according to these rules.
14 exceeded the glucose limits.
Other characteristics of the 28:
5 had chronic disease (known 3 diabetes, 1 prostatic disease, 1 hypertension)
11 had chronic disease and /or other medicine than P-pills or estrogens.
At least 2 took prescribed medicine other than P-pills or estrogens (should not have
been included)
Further exclusions?
Diseases and medications should probably be considered further:
Chronic disease and other medications than estrogens/P pills
| |
|
Chronic disease |
|
|
| |
|
No (including not answered) |
Yes |
|
| Other medication |
No (including not answered) |
2410 |
92 |
2502 |
| during last week |
Yes |
461 |
70 |
531 |
| |
|
2871 |
162 |
3033 |
Note: "other medication" should not include prescribed drugs if the inclusion
rules have been followed. In fact most of above 531 persons who have answered yes to
"other medication" only took medicine, which can be obtained without
prescription.
However some took medicine , which in Denmark only can be received according to
prescription. These persons should in fact be excluded, but this is not yet done.
Sampling conditions:
More than 50% of the individuals should have the samples taken in the fasting state
between 7.00 and 10.00 in the morning. The individual should have been out of bed for some
time and should have been sitting for a minimum of 15 minutes before bloodsampling in the
sitting position from a cubital vein with a minimum use of tourniquet.
Hours between last meal and time of sampling
| Hours |
<3 |
4 - 8 |
>8 |
| Number of individuals |
343 |
161 |
2327 |





Description of the 3035 individuals in the original sample group before exclusions
| |
|
Male |
Female |
Not answered |
| Gender |
|
47 % |
53 % |
0 % |
| |
|
|
|
|
| |
|
Yes |
No |
Not Answered |
| Nordic origin |
|
96 % |
4 % |
0 % |
| Heredity for diabetes |
|
12 % |
85 % |
3 % |
| Chronic disease |
|
5 % |
95 % |
0 % |
| Estrogens or P-pills |
(only women) |
17 % |
82 % |
0 % |
| Other medication |
|
17 % |
79 % |
4 % |
| Physical activity |
|
14 % |
86 % |
0 % |
| Blood donations |
|
16 % |
76 % |
8 % |
| Tobacco (units/day) |
0 |
1-5 |
>5 |
Not answered |
| |
83 % |
6 % |
10 % |
2 % |
| Alcohol (units/week) |
0 |
1-21 |
>21 |
Not answered |
| |
45 % |
53 % |
0 % |
1 % |
|